Kiniksa Pharmaceuticals International, plc (KNSA) on GreekSoup https://greeksoup.ai/stocks/us/knsa/ Every dated entry in the public record on Kiniksa Pharmaceuticals International, plc: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Kiniksa Pharmaceuticals International, plc Q3 FY2026 results: revenue $286 million, net income $47 millionhttps://greeksoup.ai/stocks/us/knsa/results/fy2026-q3/us:KNSA:result:2026-10-27:db912195b5Tue, 27 Oct 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/knsa/filings/us:KNSA:filing:2026-10-27:1f4e46899aTue, 27 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/knsa/filings/us:KNSA:filing:2026-10-27:54358ffd9fTue, 27 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/knsa/filings/us:KNSA:filing:2026-10-22:c5ede86917Thu, 22 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc: short interest 3,763,527 shares at the 15 October 2026 settlement, 6.78 days to coverhttps://greeksoup.ai/stocks/us/knsa/short-interest/us:KNSA:short-interest:2026-10-15:5612ebb429Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc: short interest 3,778,657 shares at the 30 September 2026 settlement, 6.41 days to coverhttps://greeksoup.ai/stocks/us/knsa/short-interest/us:KNSA:short-interest:2026-09-30:ca20373762Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc: short interest 3,876,769 shares at the 15 September 2026 settlement, 7.21 days to coverhttps://greeksoup.ai/stocks/us/knsa/short-interest/us:KNSA:short-interest:2026-09-15:fe60f3b466Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc: Form 144, Megna Michael R plans to sell 4,600 shares worth $369,380 around 3 September 2026https://greeksoup.ai/stocks/us/knsa/planned-sales/us:KNSA:planned-sale:2026-09-03:c19157b33bThu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc: Megna Michael R (CHIEF ACCOUNTING OFFICER) sold 4,600 shares (under a trading plan set in advance) at $80.30 on 3 September 2026, $369,380https://greeksoup.ai/stocks/us/knsa/insiders/us:KNSA:insider:2026-09-03:736a508309Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc: short interest 3,788,699 shares at the 31 August 2026 settlement, 8.69 days to coverhttps://greeksoup.ai/stocks/us/knsa/short-interest/us:KNSA:short-interest:2026-08-31:870cab43e5Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Kiniksa Pharmaceuticals International, plc: short interest 4,283,628 shares at the 14 August 2026 settlement, 9.56 days to coverhttps://greeksoup.ai/stocks/us/knsa/short-interest/us:KNSA:short-interest:2026-08-14:8d43f00d65Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>